Clinical Trials

Showing trials with last updates posted in October 2020.

NCT04609384 | UNKNOWN
400 participants

Nudging Effect of Timer on Surgical Rub

Study Type:
OBSERVATIONAL
Last Updated:
2020-10-30
Start Date:
2020-01-01
Completion:
2022-01-01
Conditions
  • Operation Wound; Infection
  • Bacterial Infections
  • Surgical Procedure, Unspecified
Interventions
  • DEVICE
No Results Yet
NCT04608942 | UNKNOWN | NA
25 participants

Refractory Meibomian Gland Dysfunction and Plasma Jet

Study Type:
INTERVENTIONAL
Last Updated:
2020-10-30
Start Date:
2019-11-11
Completion:
2020-08-07
Conditions
  • Meibomian Gland Dysfunction
  • Dry Eye Disease
  • Evaporative Dry Eye
  • Inflammation
  • Tear Film Deficiency
Interventions
  • DEVICE
  • PROCEDURE
No Results Yet
NCT04607473 | UNKNOWN | NA
675 participants

ABUS for Early-stage Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2020-10-30
Start Date:
2019-08-15
Completion:
2021-03-30
Conditions
  • Early Stage Breast Cancer
Interventions
  • DEVICE
No Results Yet
NCT04566952 | UNKNOWN | PHASE2
68 participants

Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2020-10-30
Start Date:
2020-10-28
Completion:
2023-03-01
Conditions
  • Ovarian Cancer
  • Ovarian and Fallopian Tube Cysts and Neoplasms
  • Neoplasms by Site
  • Neoplasms
  • Genital Neoplasms, Female
  • Urogenital Neoplasms
  • Neoplasms, Glandular and Epithelial
  • Neoplasms by Histologic Type
  • Carcinoma, Ovarian Epithelial
  • Ovarian Diseases
  • Adnexal Diseases
  • Genital Diseases, Female
  • Carcinoma
  • Anlotinib
  • PARP Inhibitors
  • BRCA1 Mutation
  • Angiogenesis
  • Antineoplastic Agents
  • BRCA2 Mutation
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page